Arax Advisory Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$435K Buy
8,701
+3,688
+74% +$184K 0.02% 426
2025
Q1
$306K Sell
5,013
-1,967
-28% -$120K 0.02% 423
2024
Q4
$395K Buy
6,980
+2,733
+64% +$155K 0.02% 342
2024
Q3
$220K Buy
4,247
+356
+9% +$18.4K 0.02% 331
2024
Q2
$162K Buy
3,891
+2,910
+297% +$121K 0.02% 371
2024
Q1
$53.2K Buy
981
+119
+14% +$6.46K 0.01% 487
2023
Q4
$44.2K Sell
862
-44
-5% -$2.26K ﹤0.01% 504
2023
Q3
$52.6K Sell
906
-118
-12% -$6.85K 0.01% 460
2023
Q2
$65.5K Sell
1,024
-515
-33% -$32.9K 0.01% 422
2023
Q1
$107K Sell
1,539
-14
-0.9% -$970 0.01% 336
2022
Q4
$112K Buy
1,553
+9
+0.6% +$647 0.02% 319
2022
Q3
$110K Sell
1,544
-666
-30% -$47.4K 0.02% 298
2022
Q2
$170K Buy
2,210
+60
+3% +$4.62K 0.03% 233
2022
Q1
$157K Sell
2,150
-2,590
-55% -$189K 0.02% 273
2021
Q4
$296K Sell
4,740
-156
-3% -$9.74K 0.04% 189
2021
Q3
$290K Buy
4,896
+230
+5% +$13.6K 0.04% 183
2021
Q2
$312K Buy
+4,666
New +$312K 0.04% 174
2020
Q4
$235K Buy
3,786
+275
+8% +$17.1K 0.03% 188
2020
Q3
$212K Sell
3,511
-2,638
-43% -$159K 0.04% 181
2020
Q2
$362K Buy
6,149
+376
+7% +$22.1K 0.06% 95
2020
Q1
$322K Buy
5,773
+17
+0.3% +$948 0.07% 95
2019
Q4
$369K Buy
5,756
+124
+2% +$7.95K 0.11% 85
2019
Q3
$286K Hold
5,632
0.09% 107
2019
Q2
$255K Buy
+5,632
New +$255K 0.08% 116
2018
Q4
$261K Buy
5,030
+2,739
+120% +$142K 0.1% 102
2018
Q3
$142K Buy
2,291
+671
+41% +$41.6K 0.06% 155
2018
Q2
$89K Sell
1,620
-131
-7% -$7.2K 0.04% 173
2018
Q1
$110K Buy
1,751
+248
+17% +$15.6K 0.06% 126
2017
Q4
$92K Buy
1,503
+9
+0.6% +$551 0.04% 154
2017
Q3
$95K Sell
1,494
-34
-2% -$2.16K 0.05% 150
2017
Q2
$85K Sell
1,528
-87
-5% -$4.84K 0.04% 170
2017
Q1
$87K Buy
1,615
+517
+47% +$27.9K 0.04% 142
2016
Q4
$64K Buy
+1,098
New +$64K 0.03% 147